| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 24, 2020
DUBLIN, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, is hiring its first Chief Inclusion and Diversity Officer, underscoring its continued...
-
Feb 19, 2020
DUBLIN, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 9th Annual SVB Leerink Global Healthcare...
-
Feb 18, 2020Revenue of $7.7 Billion Increased 2.3% Reported and 2.6% Organic
DUBLIN, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2020, which ended January 24, 2020. The company reported...
-
Feb 13, 2020Acquisition Will Accelerate Medtronic’s Strategy to Provide AI and Data Within Laparoscopic and Robotic Assisted Surgery
DUBLIN, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the acquisition of Digital Surgery, a privately-held pioneer in...
-
Feb 10, 2020Giving Includes Medtronic Foundation Cash Donations to Partners and Product Donations from the Company Including Respirator Masks, Nitrile Gloves, Ventilators and Pulse Oximeters
DUBLIN, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it and the Medtronic Foundation are committing approximately $1.2M to...
-
Feb 4, 2020SPYRAL DYSTAL Study to Evaluate the Effects of RDN Using Fewer, Targeted Ablations to Achieve Meaningful Blood Pressure Reductions
DUBLIN, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it will begin enrollment in a pilot study evaluating the safety and efficacy of the Symplicity™ Spyral renal...
-
Feb 4, 2020
DUBLIN, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for the third quarter of fiscal year 2020 on Tuesday, February 18, 2020. A...
-
Jan 30, 2020Next Generation Technology Includes Features that Automatically Adjust to Patient Needs, and Offers Physicians Heart Failure Diagnostic Insights
DUBLIN, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received CE (Conformité Européenne) Mark for its Cobalt™ and Crome™ portfolio of implantable...
-
Jan 23, 2020Efficio Software Provides Enhanced, Secure Access to Patient Data and Delivers
DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal...
-
Jan 23, 2020Investigative Technology Designed to Interrupt Irregular Pathways in the Heart
DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced that it received approval from the U.S. Food and Drug Administration (FDA) to proceed with an investigational...